Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Profound Medical (PROF) had Operating Cash Flow per Share of $-1.05 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$5.29M |
|
$-7.98M |
|
$1.36M |
|
$3.93M |
|
$14.20M |
|
$-8.91M |
|
$1.06M |
|
$-7.86M |
|
$-7.86M |
|
$-7.98M |
|
$-7.98M |
|
$-7.98M |
|
$-7.98M |
|
$-8.91M |
|
$-8.77M |
|
30.10M |
|
30.10M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$41.52M |
|
$0.34M |
|
$0.78M |
|
$42.30M |
|
$9.94M |
|
-- |
|
$0.22M |
|
$10.16M |
|
$32.14M |
|
$32.02M |
|
$32.14M |
|
30.19M |
|
| Cash Flow Statement Financials | |
$-31.64M |
|
-- |
|
$-0.29M |
|
$54.91M |
|
$24.83M |
|
$-30.09M |
|
$4.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.18 |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
74.32% |
|
-168.52% |
|
-168.52% |
|
-- |
|
-148.53% |
|
-150.82% |
|
$-31.64M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.16 |
|
0.65 |
|
138.96 |
|
-24.82% |
|
-24.91% |
|
-18.86% |
|
-24.82% |
|
$1.06 |
|
$-1.05 |
|
|
Operating Cash Flow per Share |
$-1.05 |